檢索結果 - JS Leeder
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors 由 J K Hicks, JR Bishop, Katrin Sangkuhl, Müller Dj, Yuan Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, Adrián LLerena, TC Skaar, Stuart A. Scott, Julia Stingl, Teri E. Klein, KE Caudle, Andrea Gaedigk
出版 2015Artigo -
4
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing 由 Kelly A. Birdwell, Brian S. Decker, JM Barbarino, JF Peterson, Catherine M. Stein, Wolfgang Sadée, Daqing Wang, Alexander A. Vinks, Yijing He, JJ Swen, JS Leeder, RHN van Schaik, KE Thummel, Teri E. Klein, KE Caudle, IAM MacPhee
出版 2015Artigo
相關主題
Biology
Gene
Genotype
Internal medicine
Medicine
Pharmacogenetics
Pharmacology
Biochemistry
Dosing
Pharmacokinetics
CYP2D6
Cytochrome P450
Metabolism
Psychiatry
Antidepressant
Anxiety
Area under the curve
Atomoxetine
Atomoxetine hydrochloride
Attention deficit hyperactivity disorder
CYP2C19
CYP3A5
Citalopram
Cohort
Drug
Endocrinology
Escitalopram
Fluoxetine
Fluvoxamine
Gastroenterology